 |
|
|
|
|
|
|
| Article 1 to 10 out of 16 concerning F. Hoffmann-La Roche AG
|
-
Roche NimbleGen and Affymetrix Expand Licensing Agreement
(17 Mar 2008)
Roche NimbleGen Inc., a company of Roche Applied Science, and Affymetrix Inc. announced that they have expanded the terms of the license to a number of Affymetrix patents originally granted in October 2006. The expanded license now provides certain ...
-
Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response
(11 Mar 2008)
Abbott's FISH Technology Provides Analytical Tool with Potential to Assess Clinical Response to Lung Cancer Treatment in Patients with Non-Small-Cell Lung Cancer
Abbott announced that its molecular diagnostics business has entered into an agreement with Genentech, Inc., F. Hoffmann-La Roche Ltd. and OSI Pharmaceuticals, Inc. to develop a gene test to potentially assess the clinical benefit of Tarceva(R) ...
-
New Analytica Research Prize from Roche and the GBM Strengthens Research in Germany
(25 Feb 2008)
Roche and the German Society for Biochemistry and Molecular Biology (GBM) are reorienting their joint research prize this year. Funded by Roche to the value of 50,000 euros, the prize is awarded by the GBM every two years to one or two scientists. ...
-
Transplantation Safety: New Virus Detected Using Genome Sequencer Technology
(11 Feb 2008)
454 Life Sciences, a part of Roche Applied Science, announced that researchers at Columbia University and Victorian Infectious Disease Reference Laboratory have discovered a new virus that was responsible for the deaths of three transplant ...
-
Roche to Acquire Ventana for $89.50 per share
(23 Jan 2008)
Roche and Ventana Reach Definitive Merger Agreement
Roche and Ventana Medical Systems announced that they have signed a definitive merger agreement. Under the terms of the agreement, Roche will increase the purchase price in the tender offer for Ventana common shares to $89.50 per share in cash (or ...
-
Researchers use the Genome Sequencer System to sequence and assemble the Pinot Noir Genome
(03 Jan 2008)
454 Life Sciences, a part of Roche Applied Science, announced that researchers from the Istituto Agrario San Michele all'Adige and Myriad Genetics have used the company's first generation instrument, the Genome Sequencer 20 System, to sequence and ...
-
Researchers Identify Virus Possibly Responsible for Declining Honeybee Population
(10 Sep 2007)
454 Life Sciences, a Roche company, announced that researchers at Columbia University, in collaboration with 454, have identified a virus implicated in the deaths of 2.4 million honeybee colonies - tens of billions of bees - using the company's ...
-
Roche acquires NimbleGen to gain entry into high-growth research microarrray market
(21 Jun 2007)
Roche and NimbleGen Systems Inc. announced that they have signed a definitive agreement under which Roche will acquire 100% of NimbleGen, a privately held company active in high-density DNA microarrays. Under the terms of the agreement, Roche will ...
-
Roche Diagnostics and FIND sign agreement of collaboration in diagnostics for poverty-related diseases
(04 Apr 2007)
Roche Applied Science, a business area of Roche Diagnostics, and the Foundation for Innovative New Diagnostics (FIND) have signed a Letter of Intent to further explore possibilities for the development or support of projects in the area of in-vitro ...
-
Roche acquires 454 Life Sciences to strengthen presence in ultra-fast gene sequencing
(02 Apr 2007)
Roche and CuraGen announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in high-throughput DNA sequencing. Under the terms of the ...
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon